Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-25-003444
Filing Date
2025-01-23
Accepted
2025-01-23 17:26:55
Documents
95

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 4147762
2 ex23-1.htm EX-23.1 4580
3 ex107.htm EX-FILING FEES 66901
4 forms-1_001.jpg GRAPHIC 19091
  Complete submission text file 0001493152-25-003444.txt   15724000

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aim-20240930.xsd EX-101.SCH 82977
6 XBRL CALCULATION FILE aim-20240930_cal.xml EX-101.CAL 88628
7 XBRL DEFINITION FILE aim-20240930_def.xml EX-101.DEF 405406
8 XBRL LABEL FILE aim-20240930_lab.xml EX-101.LAB 621912
9 XBRL PRESENTATION FILE aim-20240930_pre.xml EX-101.PRE 504732
99 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 3137442
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284443 | Film No.: 25551045
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)